semaglutide for menopause symptoms GLP-1s, Obesity, and Menopause: Benefits and Risks Semaglutide and Menopause Weight Loss:

Cloth Text Res J

This is reflected in our pooled meta-analysis estimate, which shows no statistically significant increase in aspiration risk (OR 1.23

Retatrutide may be considered in individuals such as: Obesity Metabolic syndrome Weight loss plateau Suboptimal response to semaglutide or tirzepatide High visceral fat levels Those aiming for fat loss while preserving lean muscle mass Suitability should always be evaluated under physician supervision

Sudden vision loss in one eye, dim or blurry central vision, or difficulty distinguishing colors warrants emergency ophthalmologic evaluation

Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, et al